Global Aptamers Market accounted for US$ 205.40 million in 2020 and is estimated to be US$ 985.44 million by 2030 and is anticipated to register a CAGR of 16.90% - By PMI
February 01, 2022 09:57 ET
|
PMI
Covina, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The report "Global Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application...
FourKites Named to Inc.’s 2021 Best in Business List in the Logistics & Transportation Category
December 08, 2021 07:30 ET
|
FourKites
CHICAGO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- FourKites®, the world’s leading real-time supply chain visibility platform, has been named to the Inc. 2021 Best in Business list in the Logistics and...
Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director
November 18, 2021 14:04 ET
|
Small Pharma Inc.
LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies,...
For the 2nd Consecutive Year, Liquipel Appears on the Inc. 5000, With Revenue Growth of 207 percent!
September 23, 2021 09:00 ET
|
Liquipel Assurance LLC
IRVINE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that Liquipel is on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private...
DISQO Ranks in Top 1000 on the 2020 Inc. 5000
August 18, 2020 11:10 ET
|
Disqo
Consumer insights platform founded on first-party audience records three-year growth of 486 percent. LOS ANGELES, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Consumer insights platform DISQO, known for...
Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.
May 22, 2020 12:35 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger transaction...
Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc.
May 19, 2020 08:00 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote count...
Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting
May 14, 2020 14:13 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 14, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter” or the “Company”), today announced that it has adjourned its special meeting of stockholders,...
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing
May 11, 2020 08:00 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice from the...
Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
May 06, 2020 09:15 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc....